Impact Partnership Wealth LLC Purchases 10,659 Shares of MetLife, Inc. $MET

Impact Partnership Wealth LLC increased its position in MetLife, Inc. (NYSE:MET) by 160.4% during the third quarter, Holdings Channel reports. The firm owned 17,304 shares of the financial services provider’s stock after buying an additional 10,659 shares during the quarter. Impact Partnership Wealth LLC’s holdings in MetLife were worth $1,425,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Quaker Wealth Management LLC boosted its stake in shares of MetLife by 198.2% during the 2nd quarter. Quaker Wealth Management LLC now owns 333 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 672 shares during the period. Evolution Wealth Management Inc. acquired a new stake in MetLife during the 2nd quarter valued at $35,000. Salomon & Ludwin LLC increased its holdings in shares of MetLife by 95.4% in the third quarter. Salomon & Ludwin LLC now owns 422 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 206 shares during the last quarter. True Wealth Design LLC raised its position in shares of MetLife by 564.1% in the third quarter. True Wealth Design LLC now owns 425 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 361 shares during the period. Finally, MTM Investment Management LLC acquired a new stake in shares of MetLife during the 2nd quarter worth about $37,000. Institutional investors own 94.99% of the company’s stock.

MetLife Stock Performance

MET opened at $78.22 on Friday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.18 and a current ratio of 0.18. MetLife, Inc. has a 52-week low of $65.21 and a 52-week high of $87.56. The firm has a market cap of $51.54 billion, a P/E ratio of 14.73, a price-to-earnings-growth ratio of 0.73 and a beta of 0.76. The business’s fifty day moving average is $78.69 and its 200-day moving average is $78.78.

MetLife (NYSE:MET) last posted its quarterly earnings data on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share for the quarter, topping the consensus estimate of $2.30 by $0.07. The business had revenue of $12.46 billion during the quarter, compared to analysts’ expectations of $18.64 billion. MetLife had a net margin of 5.30% and a return on equity of 21.00%. MetLife’s revenue was down 5.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.95 earnings per share. Sell-side analysts expect that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 3rd will be given a dividend of $0.5675 per share. The ex-dividend date is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a dividend yield of 2.9%. MetLife’s dividend payout ratio (DPR) is currently 42.75%.

Analyst Ratings Changes

MET has been the topic of several research analyst reports. Morgan Stanley set a $101.00 price target on shares of MetLife and gave the company an “overweight” rating in a report on Monday, December 15th. Barclays set a $90.00 target price on MetLife in a research note on Thursday, January 8th. UBS Group reduced their price target on MetLife from $95.00 to $94.00 and set a “buy” rating for the company in a research note on Thursday, January 8th. Weiss Ratings reissued a “buy (b-)” rating on shares of MetLife in a report on Monday, December 29th. Finally, Wells Fargo & Company upped their price target on shares of MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research note on Tuesday, January 13th. Two analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $95.27.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.